Chan Kim

Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment

Jin‐Sung Park, Il‐Kug Kim, Sangyeul Han et al. · Cancer Cell · 2016 · 315 citations

Favorable Tumor Microenvironment, Tumor Biology, Tumor Vessels +13

STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade

Hannah Yang, Won Suk Lee, So Jung Kong et al. · Journal of Clinical Investigation · 2019 · 291 citations · Full text

Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis

Yun-Ho Kim, Hye Jin Nam, Junyeop Lee et al. · Nature Communications · 2016 · 206 citations · Full text

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma

Chang Gon Kim, Chan Kim, Sang Eun Yoon et al. · Journal of Hepatology · 2020 · 187 citations · Full text

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Sumanta K. Pal, Laurence Albigès, Piotr Tomczak et al. · The Lancet · 2023 · 173 citations · Full text

Urology, Genitourinary Cancer, Medicine +7